Neurogene Inc
NASDAQ:NGNE

Watchlist Manager
Neurogene Inc Logo
Neurogene Inc
NASDAQ:NGNE
Watchlist
Price: 22.11 USD 9.78% Market Closed
Market Cap: 342.5m USD

Wall Street
Price Targets

NGNE Price Targets Summary
Neurogene Inc

Wall Street analysts forecast NGNE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NGNE is 60.18 USD with a low forecast of 46.46 USD and a high forecast of 73.5 USD.

Lowest
Price Target
46.46 USD
110% Upside
Average
Price Target
60.18 USD
172% Upside
Highest
Price Target
73.5 USD
232% Upside
Neurogene Inc Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
614% Upside
AUPH
Aurinia Pharmaceuticals Inc
7% Upside
ACLX
Arcellx Inc
81% Upside
BONEX
Bonesupport Holding AB
116% Upside
300142
Walvax Biotechnology Co Ltd
35% Downside
87S
Roivant Sciences Ltd
13% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
38% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside

Revenue
Forecast

Revenue Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Neurogene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NGNE's stock price target?
Price Target
60.18 USD

According to Wall Street analysts, the average 1-year price target for NGNE is 60.18 USD with a low forecast of 46.46 USD and a high forecast of 73.5 USD.

Back to Top